SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 18792.
  • 2
    Savage CO, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997; 349: 5538.
  • 3
    Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 108893.
  • 4
    Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 1728.
  • 5
    Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al, French Vasculitis Study Group. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001; 44: 66675.
  • 6
    Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 48898.
  • 7
    Luqmani R, Jayne D, EUVAS. A multicenter randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated vasculitis (CYCAZAREM). [abstract] Arthritis Rheum 1999; 42 Suppl 9: S225.
  • 8
    Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Q J Med 1997; 90: 4019.
  • 9
    Guillevin L, Cordier J, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40: 218798.
  • 10
    Guillevin L, Lhote F, Jarrousse B, Fain O. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: a meta-analysis of 3 prospective controlled trials including 182 patients over 12 years. Ann Méd Interne (Paris) 1992; 143: 40516.
  • 11
    Gayraud M, Guillevin L, Cohen P, Lhote F, Cacoub P, Deblois P, et al, French Cooperative Study Group for Vasculitides. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients.. Br J Rheumatol 1997; 36: 12907.
  • 12
    Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, et al. Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995; 74: 23853.
  • 13
    Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87: 6718.
  • 14
    Hagen E, Daha M, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis: EC/BCR project for ANCA assay standardization. Kidney Int 1998; 53: 74353.
  • 15
    Kaplan E, Meier P. Non parametric estimation for incomplete information. J Ann Stat Assoc 1958; 53: 45781.
  • 16
    Cox D. Regression models and life tables. J R Stat Soc 1972; 34: 187219.
  • 17
    Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Genereau T, et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis: a prospective, randomized trial in sixty-two patients. Arthritis Rheum 1995; 38: 163845.
  • 18
    Sneller MC. Cystitis, bladder cancer, and myelodysplasia in patients with Wegener's granulomatosis: comment on the article by Reinhold-Keller et al. Arthritis Rheum 2000; 43: 28535.
  • 19
    Bartolucci P, Ramanoelina J, Cohen P, Le Hello C, Guillevin L, and the French Vasculitis Study Group. Pilot study on infliximab for 10 patients with systemic vasculitis not responding to steroids and immunosuppressants. [abstract] Arthritis Rheum 2001; 44 Suppl 9: S56.
  • 20
    Lamprecht P, Voswinkel J, Lilienthal T, Noelle B, Heller M, Gross W, et al. Successful treatment of refractory Wegener's granulomatosis with infliximab. [abstract] Arthritis Rheum 2001; 44 Suppl 9: S56.
  • 21
    Bacon PA, Exley AR, Carruthers DM, Russell N, McColl G, Rentsch J, et al. Immune ablation with peripheral blood stem cell rescue in Wegener's systemic vasculitis. [abstract] Clin Exp Immunol 1998; 112: S57.